A prospective, observational study analysing Observational effects of a novel peri-infusion regimen on vital signs and infusion-associated reactions in Multiple-sclerosis patients receiving alemtuzumab
Latest Information Update: 20 Dec 2021
At a glance
- Drugs Alemtuzumab (Primary) ; Methylprednisolone; Prednisone
- Indications Multiple sclerosis
- Focus Adverse reactions
- 20 Dec 2021 New trial record